Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 3
This trial is looking at whether it is possible to give pembrolizumab less often for advanced non small lung cancer.
It is open to people with non small cell lung cancer that has:
spread into the tissue around the lungs
spread to another part of the body
Recruitment start: 23 June 2022
Recruitment end: 28 February 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Michael Seckl
Imperial College London
Imperial Clinical Trials Unit – Cancer (ICTU-Ca)
NIHR Health Technology Assessment (HTA) programme
Last reviewed: 6 April 2025
CRUK internal database number: 18054
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
